AGENDA Information of Event Schedule
Focusing on the design and manufacture of medical devices alongside factors affecting that industry (e.g., regulatory, M&A, quality, legislative), coupled with a keen awareness of challenges associated with the space, the MPO Medtech Forum presents a comprehensive agenda that targets many of today's most important issues impacting stakeholders.
State of the Industry
With an emphasis on M&A activity within the industry among OEMs and the supporting supply chain, this session will highlight the current state of affairs within the medical device manufacturing sector. Key data points and trends will be featured in this opening session, enabling predictions for future activity within the industry.
Proactive Operational Risk Assessments: Finding Risks Before They Find You
A strong operational risk assessment process is essential to preventing supply disruptions, such as those experienced during and following the pandemic, as well as those that may result from U.S. tariffs. This session will provide a structured approach to identifying risk conditions early, distinguishing show-stopper risks, and understanding supplier-specific versus industry-wide challenges. We’ll discuss why subjective scoring models can dilute real risks and how to prioritize based on impact, likelihood, and recovery time. Using real-world examples, such as the Evonik plant explosion, we’ll illustrate how deep-dive assessments and mitigation mapping can uncover hidden vulnerabilities. Attendees will gain practical strategies for conducting thorough risk assessments, collaborating with quality teams, and proactively managing supply risks. If you’re ready to move beyond surface-level risk scoring and build a more resilient supply chain, this session is for you.
Solving the Make vs. Buy Puzzle: Strategies for Medical Device OEMs
While the outsourcing of many manufacturing capabilities continues to grow, some medtech makers choose to keep a process or component fabrication in-house. What factors should be considered when making this decision? How can one decide the best course of action? This session will feature a panel discussion among industry representatives who have had to answer this question. They will share the best practices they use and their own recommendations for an effective evaluation. Moderated by Jim McCormack
Navigating Evolving FDA Priorities: Hot Topics & Global Insights
As the U.S. Food and Drug Administration (FDA) priorities continue to evolve, this session will explore key focus areas during pre-market reviews, including biocompatibility, data requirements for studies outside of the U.S., real world evidence, MRI safety, statistics, and digital health. Additionally, this session will provide insights on changes seen within the agency under the new administration and the potential impact to manufacturers. The session will also offer a high-level overview of similar regulatory trends being raised in the EU under the transition to MDR/IVDR.
Navigating the U.S. Products Liability Landscape
Doing business in the United States can be challenging for those unfamiliar with operating in a litigious environment. As such, it’s important for suppliers, especially those based outside the country, know what can be involved. This session will look at products liability in the U.S.──the quirks of a litigious society. It will also compare and contrast the U.S. and Costa Rican legal systems. In addition, essential provisions in supply chain agreements that can mitigate legal liability will be shared as well as how insurance can help a company respond to litigation threats.
A Look at Labor: Assessing Human Resources in Costa Rica
Medical device manufacturers are constantly seeking to address concerns and issues involving labor. Securing the best people for the right positions is an ongoing challenge. Companies are competing for many of the same types of candidates for roles they need to fill. This panel will look at the current situation with labor and what they are doing to help resolve problems they face. Panelists will share best practices and offer their own insights and experience in tackling this task.
Lessons Learned: Establishing a Facility in Costa Rica
Once you decide to open a facility in Costa Rica, there’s little point in reinventing the wheel. Take advantage of what others have learned who went through the process before you. This session will feature a panel of speakers who can share their insights, obstacles overcome, and best practices from having gone through the process already. They will offer their “lessons learned” to anyone interest in benefiting from being able to avoid the challenges they encountered.
Moderated by Patrick Lynch
Navigating Customs: Ensuring the Clear Transit of Products
Shipping internationally can be challenging as different countries and regions have different rules and don’t all follow the same protocols. As such, for those seeking to establish a facility in Costa Rica or anyone already operating, it’s important to know exactly what’s required to send products out and receive supplies in. This session will provide an overview of the customs system in Costa Rica. It will cover topics including customs compliance, fines and sanctions, and trade facilitation measures.